Advertisement
Demo

Sanofi drug Dupixent wins FDA approval to treat asthma

Oct 20, 2018 , Reuters
France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.


Read the full story...


Trending healthcare news keywords at this moment

medicaid digital tip polio-like cdc care fda data healthcare hospital ceo walmart ways ebola outbreak blood drug ban flavored tied heart disease treatment study smoking record diabetes risk patients cancer opioid state highlights shows hospitals doctors gun people kids google ai mental patient amp safety finds medical worst child guidelines fish oil deepmind